While the drugmaker reaffirmed its 2025 revenue guidance of $61bn to $64bn, it raised its full-year 2025 profit outlook. Pfizer now expects to earn $2.90 to $3.10 per share, compared with its previous ...

Doug Clinton, Founder and CEO of Intelligent Alpha, joins BNN Bloomberg to provide AI earnings predictions for AMD, SMCI and DIS NYSE.